Executives from Humana said Wednesday that the Medicare Advantage and Medicare Part D prescription drug plan annual election period for 2023 is going well.
The enrollment period started Oct. 15 and is set to end Dec. 7.
Bruce Broussard, the company's CEO, told securities analysts that his company expects to increase the number of individual Medicare Advantage plan enrollees by 7.1% to 8.7% in 2023.
Humana has 5 million Medicare Advantage plan enrollees and an 18% share of total Medicare Advantage plan enrollment, according to the Kaiser Family Foundation.
The Centers for Medicare and Medicaid Services, the agency that oversees Medicare plans, has implemented new marketing disclosure and call recording rules, in an effort to keep marketers and sales representatives from describing plans incorrectly.
Analysts have wondered what the new rules might do to sales.
